Anika Therapeutics, Inc., (Nasdaq: ANIK) to Ring The Nasdaq Stock Market Opening Bell
February 27 2017 - 10:22AM
What:
Anika Therapeutics, Inc., (Nasdaq:ANIK), a global, integrated
orthopedic medicines company specializing in therapeutics based on
its proprietary hyaluronic acid "HA" technology, will visit the
Nasdaq MarketSite in Times Square in celebration of its 25 year
anniversary.
In honor of the occasion, Charles H. Sherwood, Ph.D.,
President & Chief Executive Officer, will ring the
Opening Bell.
Where:Nasdaq MarketSite – 4 Times Square – 43rd
& Broadway – Broadcast Studio
When:Tuesday, February 28, 2017 – 9:15 a.m. to
9:30 a.m. ET
Anika Therapeutics Media Contact:Katie
Engleman(910) 509-3977kengleman@purecommunications.com
Nasdaq MarketSite:Emily Pan(646)
441-5120emily.pan@nasdaq.com
Feed Information:Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia features such as
exclusive content, photo postings, status updates and video of bell
ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our
Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Opening
Bell will be available at: https://new.livestream.com/nasdaq/live
or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Open, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market open of your choice.
About Anika Therapeutics, Inc.Anika
Therapeutics, Inc. (NASDAQ:ANIK) is a global, integrated
orthopedic medicines company based in Bedford, Massachusetts.
Anika is committed to improving the lives of patients with
degenerative orthopedic diseases and traumatic conditions with
clinically meaningful therapies along the continuum of care, from
palliative pain management to regenerative cartilage repair. The
Company has over two decades of global expertise developing,
manufacturing, and commercializing more than 20 products based on
its proprietary hyaluronic acid (HA) technology. Anika's
orthopedic medicine portfolio
includes ORTHOVISC®, MONOVISC®, and CINGAL®, which
alleviate pain and restore joint function by replenishing depleted
HA, and HYALOFAST®, a solid HA-based scaffold to aid cartilage
repair and regeneration. For more information about Anika, please
visit www.anikatherapeutics.com.
About NasdaqNasdaq (Nasdaq:NDAQ) is a leading
provider of trading, clearing, exchange technology, listing,
information and public company services across six continents.
Through its diverse portfolio of solutions, Nasdaq enables clients
to plan, optimize and execute their business vision with
confidence, using proven technologies that provide transparency and
insight for navigating today's global capital markets. As the
creator of the world's first electronic stock market, its
technology powers more than 85 marketplaces in 50 countries, and 1
in 10 of the world's securities transactions. Nasdaq is home to
approximately 3,800 listed companies with a market value of $10.1
trillion and nearly 18,000 corporate clients. To learn more, visit:
business.nasdaq.com.
-NDAQA-
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Feb 2024 to Mar 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Mar 2023 to Mar 2024